Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Erfurt
Clinical trial register · Germany

Clinical Trials in Erfurt, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca3 Merck Sharp & Dohme LLC3 Eli Lilly and Company2 Boehringer Ingelheim2 Insel Gruppe AG, University Hospital Bern2
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Erfurt

52 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Bayer
Phase 1
36
Heidelberg, Bonn, Erfurt, Berlin
2027-01-01
Not yet open
Dalbavancin Therapy for Infective Endocarditis
NCT07699211Endocarditis Infective, Endocarditis, Bacterial
DrugDalbavancin administration
Stefan Hagel
Phase 3
184
Freiburg im Breisgau, Regensburg, Hamburg, Cologne, Leipzig, Berlin, Erfurt, Jena
2026-12
Recruiting
Xenios AG
Observational
20
Erfurt, Aachen, Solingen
2026-05-19
Recruiting
Targeting Real World Usage In Stroke Treatment
NCT07474935Saccular and Fusiform Aneurysms, Pseudoaneurysm, Vascular Dissection, Perforation
Phenox GmbH
Observational
5,000
Erfurt, Hamburg, Heidelberg, München, Nuremberg
2026-01-29
Active, closed
WATCHMAN FLX Pro European Registry
NCT07262255Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure
Boston Scientific Corporation
Observational
189
Bad Oeynhausen, Berlin, Erfurt, Hamburg, Lübeck
2025-12-17
Recruiting
University Hospital Schleswig-Holstein
Not applicable
175
Frankfurt am Main, Munich, Kiel, Erfurt
2025-12-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Stuttgart, Tübingen, Göttingen, Schwerin, Herne, Münster, Dresden, Erfurt
2025-11-26
Recruiting
Universität des Saarlandes
Phase 3
214
Berlin, Chemnitz, Darmstadt, Dresden, Erfurt, Erlangen, Frankfurt am Main, Giessen
2025-10-30
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Leipzig, Coburg, Erfurt, Essen, Hennigsdorf, Kiel
2025-10-03
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
34
Erfurt, Erlangen, Heidelberg, Leipzig, Minden, Oberhausen, Tübingen
2025-08-07
Recruiting
Celgene
Phase 3
400
Ulm, Augsburg, Göttingen, Dortmund, Düsseldorf, Münster, Homburg, Erfurt
2025-07-28
Active, closed
Support C Post-Market Registry
NCT06678490Coronary Arteriosclerosis
OrbusNeich
Observational
282
Erfurt, Hagen, Lahr, Nuremberg
2025-07-09
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bad Friedrichshall, Bamberg, Berlin, Bonn, Bünde, Coburg, Dresden, Erfurt
2025-05-20
Recruiting
Eli Lilly and Company
Phase 3
700
Berlin, Chemnitz, Cologne, Erfurt, Gauting, Georgsmarienhütte, Großhansdorf, Halle
2025-03-27
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Karlsbad, Bad Neustadt an der Saale, Bamberg, Bochum, Bottrop, Erfurt, Essen, Frankfurt
2025-03-14
Recruiting
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
NCT07091682Coronary Artery Disease, Atherosclerosis of Coronary Artery, Myocardial Ischemia, Ischemic Heart Disease
Biotronik AG
Not applicable
100
Erfurt, Halle, Immenstadt and Kempten, München
2025-02-18
Recruiting
Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NCT06672081Pulmonary Embolism Acute Massive
Leipzig Heart Science gGmbH
Not applicable
210
Bad Krozingen, Bautzen, Bonn, Düsseldorf, Erfurt, Frankfurt am Main, Halle, Hamburg
2024-12-27
Recruiting
Cytokinetics
Phase 3
1,800
Heidelberg, München, Würzburg, Hamburg, Erfurt, Jena, Mainz, Bad Nauheim
2024-12-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
67
Erfurt, Jena
2024-11-21
Active, closed
Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany
NCT06675552Heart Disease, Heart Failure, Cardiovascular Disease, Heart Failure, Systolic
AstraZeneca
Observational
338
Berlin, Erfurt, Gifhorn, Leipzig, Schwerin, Wuppertal
2024-11-15
Recruiting
Replimune, Inc.
Phase 3
400
Berlin, Dresden, Erfurt, Essen, Hamburg, Heidelberg, Kiel, Mainz
2024-07-11
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Aachen, Bad Friedrichshall, Berlin, Bonn, Dessau, Dresden, Erfurt, Frankfurt
2024-06-17
Recruiting
Immunocore Ltd
Phase 3
680
Berlin, Bremen, Dortmund, Dresden, Erfurt, Erlangen, Essen, Frankfurt
2024-06-05
Recruiting
Daiichi Sankyo
Phase 3
540
Berlin, Erfurt, Essen, Frankfurt, Frankfurt am Main, Gauting, Gera, Giessen
2024-05-21
Recruiting
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
NCT04183660Cardiac Failure, Respiratory Failure, Cardio-Respiratory Failure, Imminent Cardiorespiratory or Respiratory Failure
Hemovent GmbH
Observational
60
Hanover, Essen, Halle, Erfurt
2024-04-30
Recruiting
AstraZeneca
Phase 3
582
Berlin, Cologne, Erfurt, Frankfurt, Göttingen, Immenhausen, Kiel, Mainz
2024-04-29
Active, closed
Novo Nordisk A/S
Phase 3
673
Bremen, Dresden, Elsterwerda, Erfurt, Frankfurt, Freiburg im Breisgau, Fulda, Homburg
2024-04-01
Recruiting
Eli Lilly and Company
Phase 3
1,264
Berlin, Chemnitz, Cologne, Donauwörth, Erfurt, Freiburg im Breisgau, Gauting, Georgsmarienhütte
2023-12-21
By invitation
Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica
NCT06133530Healthy Adults, High Altitude, Isolation, Social
IU University of Applied Sciences
Not applicable
26
Erfurt
2023-09-24
Recruiting
Hoffmann-La Roche
Phase 3
230
Amberg, Berlin, Bottrop, Düsseldorf, Erfurt, Erlangen, Freiburg im Breisgau, München
2023-09-08
Active, closed
Bristol-Myers Squibb
Phase 3
579
Heidelberg, Ulm, Regensburg, Lübeck, Berlin, Buxtehude, Dortmund, Erfurt
2023-03-06
Recruiting
Acandis GmbH
Observational
153
Aschaffenburg, Augsburg, Bonn, Bremerhaven, Dresden, Duisburg, Erfurt, Halle
2023-01-25
Recruiting
Promedon
Observational
140
Chemnitz, Erfurt, Freiburg im Breisgau, Kassel, Leipzig, Mannheim, Tettnang
2022-12-19
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
209
Bönnigheim, Bramsche, Bretten, Erfurt, Goch, Hamburg, Mönchengladbach, Schönau am Königssee
2022-08-23
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Bad Homburg, Berlin, Bremen, Chemnitz, Dortmund, Dresden, Elsterwerda, Erfurt
2022-02-07
Active, closed
AstraZeneca
Phase 3
1,051
Erfurt, Erlangen, Essen, Esslingen am Neckar, Georgsmarienhütte, Gütersloh, Hanover, Oldenburg
2022-02-07
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Aachen, Berlin, Bremen, Dresden, Erfurt, Frankfurt, Göttingen, Hamburg
2021-12-09
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Amberg, Bayreuth, Berlin, Cologne, Düsseldorf, Erfurt, Frankfurt, Halle
2021-08-25
Active, closed
HUYABIO International, LLC.
Phase 3
450
Berlin, Cologne, Dresden, Erfurt, Essen, Freiburg im Breisgau, Heidelberg, Leipzig
2021-08-12
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Augsburg, Bad Nauheim, Berlin, Bonn, Bottrop, Dessau, Düsseldorf, Erfurt
2021-05-04
Recruiting
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
NCT04844944Heart Failure, Coronary Artery Disease, Atrial Fibrillation
Helios Health Institute GmbH
Observational
24,000
Berlin, Erfurt, Gifhorn, Hildesheim, Leipzig, Plauen, Schwerin, Siegburg
2021-03-30
Active, closed
Promedon
Not applicable
180
Erfurt, Berlin, Freiburg im Breisgau, Leipzig, Tettnang, Tübingen
2021-03-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Freiburg im Breisgau, Heidelberg, Nuremberg, Frankfurt am Main, Aachen, Homburg/ Saar, Halle, Erfurt
2021-02-25
Recruiting
Occlutech International AB
Observational
150
Bottrop, Coburg, Cologne, Erfurt, Hamburg, Heide, Jena, Osnabrück
2020-10-28
Active, closed
CHAMPION-AF Clinical Trial
NCT04394546Atrial Fibrillation, Stroke, Bleeding
DrugsNon-Vitamin K Anticoagulant·NOAC
Boston Scientific Corporation
Not applicable
3,000
Berlin, Coburg, Dresden, Erfurt, Essen, Frankfurt, Hamburg, Lübeck
2020-10-15
Active, closed
University Hospital, Essen
Phase 3
374
Würzburg, Rostock, Augsburg, Bochum, Dortmund, Dresden, Erfurt, Essen
2020-07-01
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
NCT04075084Tachycardia, Atrial Fibrillation, Syncope, Bradycardia
Biotronik SE & Co. KG
Observational
1,400
Ahaus, Bad Nauheim, Bad Neustadt an der Saale, Dresden, Erfurt, Herford, Leipzig, Mitte
2019-10-28
Active, closed
University Hospital Tuebingen
Phase 3
1,065
Amberg, Augsburg, Bad Kreuznach, Bremen, Dresden, Düsseldorf, Erfurt, Esslingen am Neckar
2018-07-27
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Heidelberg, Tübingen, Quedlinburg, Buxtehude, Cologne, Erfurt, Essen, Hanover
2018-04-11
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Augsburg, Berlin, Bochum, Erfurt, Erlangen, Essen, Freiburg im Breisgau, Hamburg
2016-12
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Leipzig, Berlin, Chemnitz, Dresden, Erfurt, Gauting, Gera, Göttingen
2016-09-13
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Erfurt, Münster
2015-05-01
Rows per page Showing 1–52 of 52
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/erfurt

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 52 of those studies with a site in Erfurt.

How many clinical trials are recruiting in Erfurt?

29 of the 52 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 20 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Erfurt), 52 studies
PhaseStudiesRecruitingShare
Phase 3261450%
Observational13925%
Not applicable7313.5%
Phase 2325.8%
Phase 1101.9%
Phase 2/3101.9%
Phase 4111.9%

Most active sponsors

Lead sponsors with the most studies (Erfurt)
Lead sponsorStudiesRecruiting
AstraZeneca31
Merck Sharp & Dohme LLC31
Boehringer Ingelheim22
Boston Scientific Corporation20
Bristol-Myers Squibb20
Eli Lilly and Company22
Hoffmann-La Roche21
Insel Gruppe AG, University Hospital Bern22
Promedon21
Acandis GmbH11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.